Tilray Brands (TLRY) Operating Income (QoQ) (2017 - 2026)
Tilray Brands (TLRY) Operating Income (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -18.43% |
| Nov 30, 2025 | -1,164.96% |
| Aug 31, 2025 | 100.14% |
| May 31, 2025 | -90.02% |
| Feb 28, 2025 | -1,700.02% |
| Nov 30, 2024 | -15.44% |
| Aug 31, 2024 | -121.29% |
| May 31, 2024 | 79.87% |
| Feb 29, 2024 | -96.60% |
| Nov 30, 2023 | -21.53% |
| Aug 31, 2023 | 61.81% |
| May 31, 2023 | 92.54% |
| Feb 28, 2023 | -2,230.01% |
| Nov 30, 2022 | -144.55% |
| Aug 31, 2022 | 95.47% |
| May 31, 2022 | -2,485.30% |
| Feb 28, 2022 | 67.44% |
| Nov 30, 2021 | 19.95% |
| Aug 31, 2021 | 5.86% |
| May 31, 2021 | -206.39% |